Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

ProShares UltraPro Short Nasdaq Biotechnology (ZBIO) News Today

ProShares UltraPro Short Nasdaq Biotechnology logo
Last Week's 3 Biotech IPOs Prompt Huge Insider Buying
ProFunds Short NASDAQ-100 Svc
Nasdaq Biotechnology Index NBI
ProShares UltraPro Short Nasdaq Biotechnology (ZBIO)
Get ProShares UltraPro Short Nasdaq Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.

ZBIO Media Mentions By Week

ZBIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZBIO
News Sentiment

0.00

0.74

Average
Medical
News Sentiment

ZBIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZBIO Articles
This Week

2

0

ZBIO Articles
Average Week

Get ProShares UltraPro Short Nasdaq Biotechnology News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ZBIO) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners